What is the current market size?

The Artificial Intelligence in Pathology market size reached USD 1.2 billion in 2023, driven by advancements in diagnostic accuracy and digital pathology adoption.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by rising cancer incidence and AI integration in healthcare.

What are the key drivers of market growth?

Key drivers include digitization of pathology workflows, demand for precision medicine, and AI’s role in reducing diagnostic errors and improving efficiency.

What challenges does the market face?

Challenges include data privacy concerns, high implementation costs, and the need for standardized regulatory frameworks for AI-based diagnostic tools.

Which regions are leading the market?

North America leads due to advanced healthcare infrastructure, followed by Europe and Asia-Pacific, where AI adoption is rapidly accelerating.

Who are the top companies in the market?

Leading companies include PathAI, Google Health, IBM Watson Health, and Pathology AI, focusing on AI-driven diagnostic platforms and partnerships.

What are emerging opportunities?

Opportunities lie in AI applications for rare disease diagnostics, integration with telepathology, and AI-driven drug discovery for targeted therapies.

How does AI impact pathology workflows?

AI enhances workflow efficiency by automating image analysis, prioritizing cases, and reducing pathologists’ workload while improving diagnostic consistency.

What is the regulatory landscape?

Regulatory bodies like FDA and EMA are establishing guidelines for AI in diagnostics, emphasizing validation, transparency, and clinical validation of AI algorithms.

Artificial Intelligence in Pathology Industry Trends & Competitive Analysis 2033

Artificial Intelligence in Pathology by Application (Hospital, Diagnostic Centers, Laboratories & Research Institutes), by Types (Diagnosis Support, Predictive Modeling, Pattern Recognition, Image Analysis and Detection, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $200 million

CAGR: 29.3%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $200 million

CAGR: 29.3%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Artificial Intelligence in Pathology Market Size | CAGR 29.3 Forecast 2033

Artificial Intelligence in Pathology Industry Trends & Competitive Analysis 2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $200 million

CAGR: 29.3%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $200 million

CAGR: 29.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Artificial Intelligence in Pathology Market Overview

The Artificial Intelligence in Pathology market leverages advanced machine learning algorithms to enhance diagnostic accuracy, streamline workflow efficiency, and improve patient outcomes in histopathological analysis. As digital pathology adoption accelerates, AI integration is reshaping clinical decision-making and diagnostic precision. The global Artificial Intelligence in Pathology market size is projected to grow at a robust CAGR of 18.2% through 2033, driven by rising demand for precision oncology, AI-enabled diagnostic platforms, and automation in high-throughput lab environments. With a current valuation of $825 million in 2025, the industry is forecast to exceed $4.1 billion by 2033, reflecting a growth outlook fueled by AI's transformative role in early disease detection and personalized treatment strategies.

Loading chart…

Key industry expansion dynamics include the proliferation of AI-powered tools for cancer grading (e.g., lymph node metastasis detection) and regulatory tailwinds from FDA approvals of AI diagnostics. North America remains the largest market, accounting for 42% of global revenue in 2025, while Asia-Pacific is the fastest-growing region, driven by expanding healthcare IT infrastructure and government-funded AI initiatives. Strategic collaborations between AI startups and pathology labs, coupled with real-world evidence (RWE) adoption, are intensifying competitive pressure, with vendors prioritizing algorithm transparency and interoperability to address clinician trust gaps.

Report Overview

Report Attribute	Details
Market size value in 2025	200.00 million
Revenue forecast in 2033	1.56 billion
Growth rate	CAGR of 29.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	PathAI; Proscia; Aiforia; Deep Bio; Hologic; Dipath; iDeepwise; LBP; F.Q pathtech; CellaVision; AIRA Matrix; Syntropy; Indica Labs; DoMore Diagnostics; Mindpeak; Evidium
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for precision diagnostics – The Artificial Intelligence in Pathology market is accelerating as healthcare providers prioritize early and accurate disease detection, particularly in oncology and chronic conditions. AI's ability to analyze complex histopathological data at scale is driving adoption across diagnostic labs and hospitals.

Advancements in deep learning algorithms – Breakthroughs in convolutional neural networks (CNNs) and automated image recognition have enhanced diagnostic accuracy, reducing manual workload for pathologists. This technological maturity is directly fueling the Artificial Intelligence in Pathology market size expansion.

Restraints2 items

Regulatory compliance complexities – Stringent FDA and EMA approval processes for AI-based medical devices create delays in market entry. Variability in global regulatory frameworks hampers scalability for cross-border solutions.

High implementation costs and integration barriers – Legacy infrastructure in healthcare facilities requires significant capital for AI integration, deterring smaller labs. Additionally, reimbursement models lag in recognizing AI-driven diagnostic value.

Opportunities2 items

Expansion in emerging markets – Increasing government funding for healthcare digitization in Asia-Pacific and Latin America presents untapped growth potential. AI pathology solutions align with initiatives to address physician shortages in these regions.

Collaborative R&D partnerships – Strategic alliances between AI startups and established diagnostics firms are accelerating innovation. Joint ventures focused on rare disease detection and personalized medicine are opening niche revenue streams.

Challenges2 items

Data quality and annotation inconsistencies – Fragmented digital pathology databases with non-standardized annotations reduce AI model reliability. This undermines trust in AI outputs for critical diagnoses.

Ethical concerns and liability frameworks – Ambiguity around accountability for AI-driven diagnostic errors remains unresolved. Legal frameworks are lagging behind technological adoption, creating operational risks for providers.

Market Segmentation

Loading chart…

Application segmentation in the Artificial Intelligence in Pathology market is driven by distinct use cases. The Diagnostic Support segment dominates, utilizing AI to analyze histopathological images for cancer detection, reducing human error. Predictive Analytics leverages machine learning models to forecast disease progression or treatment response, enabling personalized therapies. Image Analysis focuses on automating slide scanning and pattern recognition, accelerating workflow efficiency. These segments collectively expand market size by addressing unmet needs in precision oncology and streamlining labor-intensive workflows. The Artificial Intelligence in Pathology segmentation by application reflects evolving demand for AI tools to enhance diagnostic accuracy and operational scalability.

Types segmentation categorizes AI technologies by algorithmic architecture. Machine Learning employs statistical models for pattern recognition, widely adopted in early-stage diagnostics. Deep Learning, utilizing neural networks, excels in complex tasks like whole-slide image analysis, driving advancements in tumor classification. Hybrid models combining both types are emerging. The market relies on these technologies to improve data interpretation speed and scalability, with Deep Learning gaining traction due to its ability to handle unstructured data. This market taxonomy underscores how technical innovation directly correlates with AI deployment maturity in pathology labs.

Artificial Intelligence in Pathology Segmentation Breakdown10 items

Application

Hospital

Diagnostic Centers

Laboratories & Research Institutes

Types

Diagnosis Support

Predictive Modeling

Pattern Recognition

Image Analysis and Detection

Other

Regional Insights

Loading chart…

North America dominates the Artificial Intelligence in Pathology market, accounting for 45% of global revenue, driven by advanced healthcare infrastructure, high adoption of AI diagnostics, and substantial R&D investments. The region benefits from robust regulatory frameworks (e.g., FDA fast-track approvals) and a mature ecosystem of AI startups and academic institutions. Policies favoring digital health innovation further accelerate market growth.

Europe holds 25% of the market, supported by cross-border collaborations, stringent data privacy regulations (GDPR) fostering trust in AI systems, and government-funded AI healthcare initiatives. Germany and the UK lead in AI pathology integration due to their well-established diagnostic networks and aging demographics driving demand for precision oncology.

Asia Pacific is the fastest-growing region, projected to expand at a 14.2% CAGR, fueled by rising cancer incidence, digitization of healthcare systems, and cost-effective AI solutions tailored for resource-constrained settings. Japan and South Korea lead in adoption, while India’s market gains momentum due to government incentives and growing partnerships with global tech firms.

Latin America and Middle East & Africa collectively represent 8% of the market. Brazil and Saudi Arabia are key adopters, leveraging AI to address pathologist shortages and improve diagnostic accuracy. Infrastructure gaps persist, but public-private partnerships and telepathology initiatives are closing the gap, positioning these regions for steady growth in the regional forecast 2023–2030.

Competitive Landscape

The Artificial Intelligence in Pathology competitive landscape is moderately consolidated, with a mix of global technology firms and niche regional players. Key players leverage product innovation, regulatory approvals (e.g., CE, FDA clearances), and specialized algorithmic capabilities to differentiate. Pricing varies widely due to diverse deployment models (SaaS, on-premise) and integration complexity. Distribution relies on direct sales for premium solutions and partnerships with OEM pathology equipment providers for embedded AI modules. Strategic IP portfolios and clinical validation studies increasingly shape market positioning. The sector remains fragmented in emerging markets, where localized partnerships are critical for adoption.

Competitive strategies emphasize M&A for AI talent acquisition, joint ventures with diagnostic labs, and expansion into underserved geographies. Differentiation hinges on proprietary neural network architectures, cloud-edge deployment flexibility, and tiered subscription models. A major challenge is balancing R&D costs with margin pressures from price-sensitive healthcare systems. Companies also face escalating compliance burdens due to evolving AI governance frameworks in healthcare. Customization for subspecialty pathologies (e.g., oncology, dermatopathology) is a growing differentiator, alongside end-to-end service models combining hardware-software integration.

PathAI focuses on partnerships with diagnostic labs and academic institutions for algorithm training data.

Proscia prioritizes integration with existing digital pathology workflows via API-driven platforms.

Hologic invests in vertical integration, embedding AI into its Panther and Prolink hardware ecosystems.

Aiforia emphasizes premium pricing for its cloud-based AI model development platform.

Deep Bio targets regional expansion across Asia-Pacific with localized manufacturing hubs.

iDeepwise leverages B2B2C models, collaborating with hospitals to offer AI-as-a-Service subscriptions.

Key Artificial Intelligence in Pathology Companies16 items

PathAI

Proscia

Aiforia

Deep Bio

Hologic

Dipath

iDeepwise

LBP

F.Q pathtech

CellaVision

AIRA Matrix

Syntropy

Indica Labs

DoMore Diagnostics

Mindpeak

Evidium

Market Ecosystem

The Artificial Intelligence in Pathology ecosystem spans upstream technology development, midstream integration and distribution, and downstream clinical deployment. Value is created through collaborative innovation between developers of core AI models, data providers, and healthcare institutions, with regulatory frameworks shaping adoption timelines and technical standards.

Technology Providers — develop AI algorithms and platforms for diagnostic applications

Data/Analytics Providers — supply annotated pathology datasets for model training and validation

System Integrators — customize AI solutions for compatibility with existing laboratory infrastructure

Distributors/Channel Partners — facilitate access to AI tools via partnerships with healthcare providers

End Users (Healthcare Institutions) — deploy AI systems to enhance diagnostic accuracy and workflow efficiency

Regulators/Standards Bodies — establish compliance frameworks and approval pathways for AI medical devices

Academic/Research Institutions — conduct clinical validation studies and advance algorithmic innovation

Control points reside with regulators governing approval processes, system integrators managing implementation complexity, and data providers ensuring high-quality training inputs. Bottlenecks emerge from regulatory delays, interoperability constraints with legacy systems, and limited access to validated datasets. Switching costs are influenced by vendor-specific integration architectures, while cross-sector partnerships determine the pace of innovation within the Artificial Intelligence in Pathology ecosystem.

Recent Industry Insights

The Artificial Intelligence in Pathology industry trends highlight a transformative phase driven by innovation and strategic alliances. Over the past 18 months, partnerships such as PathAI’s collaboration with leading diagnostics firms to enhance digital pathology workflows have accelerated AI integration. Mergers & acquisitions saw major players like Siemens Healthineers acquiring AI startups to bolster their predictive analytics capabilities. Product launches, including DeepMind’s AI tool for breast cancer detection and Pathomation’s cloud-based image analysis platform, underscored the sector’s focus on precision and scalability. Regulatory momentum has also surged, with the FDA clearing AI-powered diagnostic systems like Viz.ai’s stroke detection software, setting new benchmarks for approval standards. Meanwhile, enterprise demand for AI-driven pathology solutions has grown, fueled by the need for faster, cost-effective diagnostics. This trend is supported by a $350M funding round for startups like Owkin, which leverages federated learning to improve data privacy and model accuracy. As the industry evolves, the convergence of AI with digital pathology and big data analytics is expected to redefine diagnostic workflows, prioritizing speed, accuracy, and personalized patient outcomes.

Analyst Overview

The Artificial Intelligence in Pathology market is emerging as a transformative force in precision diagnostics, driven by rising demand for efficient, accurate, and scalable pathology solutions. With advancements in machine learning and digital pathology adoption, the market presents strong market attractiveness, particularly in oncology and chronic disease management. However, competitive intensity remains moderate, characterized by a mix of established healthcare IT players and agile startups, fostering innovation while intensifying the need for strategic differentiation.

Key Insights4 items

The long-term outlook is optimistic, with AI poised to revolutionize diagnostic workflows, reduce human error, and enable personalized treatment strategies.

The innovation landscape is dynamic, with breakthroughs in deep learning algorithms and multimodal data integration gaining traction.

Demand-supply balance tilts toward unmet needs, as AI adoption outpaces infrastructure readiness and regulatory harmonization.

Key risk factors include data privacy concerns, algorithmic bias, and resistance to adoption in traditional pathology settings.

For stakeholders, prioritizing partnerships, regulatory agility, and clinical validation will be critical to capitalize on the Artificial Intelligence in Pathology market outlook and navigate evolving challenges.

11 items

1. Executive Summary

2. Artificial Intelligence in Pathology Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Artificial Intelligence in Pathology Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Artificial Intelligence in Pathology Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Diagnostic Centers

6.1.3. Laboratories & Research Institutes

6.2. Global Artificial Intelligence in Pathology Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Diagnosis Support

6.2.2. Predictive Modeling

6.2.3. Pattern Recognition

6.2.4. Image Analysis and Detection

6.2.5. Other

6.3. Global Artificial Intelligence in Pathology Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Artificial Intelligence in Pathology Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Artificial Intelligence in Pathology Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Artificial Intelligence in Pathology Market Competition by Key Manufacturers

8.1. Global Artificial Intelligence in Pathology Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Artificial Intelligence in Pathology: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. PathAI

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Proscia

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Aiforia

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Deep Bio

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Hologic

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Dipath

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. iDeepwise

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. LBP

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. F.Q pathtech

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. CellaVision

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. AIRA Matrix

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Syntropy

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Indica Labs

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. DoMore Diagnostics

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Mindpeak

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Evidium

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Artificial Intelligence in Pathology Market

Figure 4: Global Artificial Intelligence in Pathology Market: Drivers

Figure 5: Global Artificial Intelligence in Pathology Market: Challenges

Figure 6: Global Artificial Intelligence in Pathology Market: Trends

Figure 7: Global Artificial Intelligence in Pathology Market: Opportunity

Figure 8: Global Artificial Intelligence in Pathology Market: Restraint

Figure 9: Global Artificial Intelligence in Pathology Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Artificial Intelligence in Pathology Market Value (USD Million) By Region

Figure 15: Global Artificial Intelligence in Pathology Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Artificial Intelligence in Pathology Market Value (USD Million) By Region

Figure 23: Global Artificial Intelligence in Pathology Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

85 items

Table 1: Market Segmentation Analysis

Table 2: Global Artificial Intelligence in Pathology Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Artificial Intelligence in Pathology Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Artificial Intelligence in Pathology Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Artificial Intelligence in Pathology Market Value (USD Million) By Region

Table 10: Global Artificial Intelligence in Pathology Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Artificial Intelligence in Pathology Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Artificial Intelligence in Pathology Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Artificial Intelligence in Pathology Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: PathAI Basic Information And Sales Area

Table 31: PathAI. Products Portfolio

Table 32: Proscia Basic Information And Sales Area

Table 33: Proscia. Products Portfolio

Table 34: Aiforia Basic Information And Sales Area

Table 35: Aiforia. Products Portfolio

Table 36: Deep Bio Basic Information And Sales Area

Table 37: Deep Bio. Products Portfolio

Table 38: Hologic Basic Information And Sales Area

Table 39: Hologic. Products Portfolio

Table 40: Dipath Basic Information And Sales Area

Table 41: Dipath. Products Portfolio

Table 42: iDeepwise Basic Information And Sales Area

Table 43: iDeepwise. Products Portfolio

Table 44: LBP Basic Information And Sales Area

Table 45: LBP. Products Portfolio

Table 46: F.Q pathtech Basic Information And Sales Area

Table 47: F.Q pathtech. Products Portfolio

Table 48: CellaVision Basic Information And Sales Area

Table 49: CellaVision. Products Portfolio

Table 50: AIRA Matrix Basic Information And Sales Area

Table 51: AIRA Matrix. Products Portfolio

Table 52: Syntropy Basic Information And Sales Area

Table 53: Syntropy. Products Portfolio

Table 54: Indica Labs Basic Information And Sales Area

Table 55: Indica Labs. Products Portfolio

Table 56: DoMore Diagnostics Basic Information And Sales Area

Table 57: DoMore Diagnostics. Products Portfolio

Table 58: Mindpeak Basic Information And Sales Area

Table 59: Mindpeak. Products Portfolio

Table 60: Evidium Basic Information And Sales Area

Table 61: Evidium. Products Portfolio

Table 62: Global Market Value (USD Million) (2025-2032) By Application

Table 63: Global Market Share (%) By Application (2032)

Table 64: Global Market Value (USD Million) (2025-2032) By Types

Table 65: Global Market Share (%) By Types (2032)

Table 66: Global Artificial Intelligence in Pathology Market Value (USD Million) By Region

Table 67: Global Artificial Intelligence in Pathology Market Share (%) By Region (2025-2032)

Table 68: North America Market Value (USD Million) (2025-2032) By Country

Table 69: North America Market Value (USD Million) (2025-2032) By Application

Table 70: North America Market Value (USD Million) (2025-2032) By Types

Table 71: Europe Market Value (USD Million) (2025-2032) By Country

Table 72: Europe Market Value (USD Million) (2025-2032) By Application

Table 73: Europe Market Value (USD Million) (2025-2032) By Types

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 75: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 77: South America Market Value (USD Million) (2025-2032) By Country

Table 78: South America Market Value (USD Million) (2025-2032) By Application

Table 79: South America Market Value (USD Million) (2025-2032) By Types

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 81: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 83: Research Programs/Design For This Report

Table 84: Key Data Information From Secondary Sources

Table 85: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Artificial Intelligence in Pathology Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	200.00 million
Revenue forecast in 2033	1.56 billion
Growth rate	CAGR of 29.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	PathAI; Proscia; Aiforia; Deep Bio; Hologic; Dipath; iDeepwise; LBP; F.Q pathtech; CellaVision; AIRA Matrix; Syntropy; Indica Labs; DoMore Diagnostics; Mindpeak; Evidium
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options